Severe COVID-19 linked to overactive immune cells, study says
Photo Cred: Edward Jenner/Pexels By Katherine Shagoury Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe novel coronavirus (COVID-19) cases, according...
Read MoreAir pollution may make coronavirus more severe for some patients
Photo Cred: Lukas Kloeppel/Pexels By Katherine Shagoury Long-term exposure to urban air pollution may have made the novel coronavirus (COVID-19) more deadly for some, according to a new study by...
Read MoreCBD could reduce lung damage from COVID-19
Photo Cred: Oliver King/Pexels By Katherine Shagoury Cannabidiol (CBD) appears to reduce the cytokine storm that damages the lungs and kills many patients with the novel coronavirus (COVID-19) by enabling...
Read MoreLink between blood type and COVID-19 susceptibility, study finds
Photo Cred: Edward Jenner/Pexels By Katherine Shagoury People with blood type O may have a lower risk of novel coronavirus (COVID-19) infection and reduced likelihood of severe outcomes, including organ...
Read MoreCMS proposed fee schedule poses challenges for acupuncture reimbursement
Photo Cred: Louis Velazquez/Unsplash By David Miller, MD, LAc, and Margaret Chesney, PhD The Centers for Medicare and Medicaid Services (CMS) announced on August 5 its fee schedule that will...
Read MoreResearch finds yoga, mindfulness meditation reduce chronic pain
Photo Cred: Elly Fairytale/Pexels By Katherine Shagoury A mindfulness-based stress reduction (MBSR) course was found to benefit patients with chronic pain and depression, leading to significant improvement in participant perceptions...
Read MoreBrain fog following COVID-19 may indicate PTSD, study finds
Photo Cred: Gustavo Fring/Pexels By Katherine Shagoury Lingering brain fog and other neurological symptoms after the novel coronavirus (COVID -19) recovery may be due to post-traumatic stress disorder (PTSD), an...
Read MoreJohnson & Johnson pauses COVID-19 vaccine trial
Photo Cred: Freestocks.org/Pexels By Katherine Shagoury Updated: October 14, 2020 Johnson & Johnson announced it would be temporarily halting its novel coronavirus (COVID-19) vaccine candidate clinical trials due to an...
Read More